These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10765114)

  • 1. Influence of mycophenolic acid and FK-506 on human platelet activation in vitro.
    Klein BC; Bach D; Rehfeld I; Kirchhoff E; Hohlfeld T; Schrör K; Scharf R; Grabensee B
    Kidney Blood Press Res; 2000; 23(2):119-24. PubMed ID: 10765114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of calcineurin inhibitors on endothelial and platelet function in renal transplant patients.
    Sahin G; Akay OM; Bal C; Yalcin AU; Gulbas Z
    Clin Nephrol; 2011 Sep; 76(3):218-25. PubMed ID: 21888859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of mycophenolate mofetil and mycophenolic acid on platelet aggregation in vitro.
    Malyszko J; Malyszko JS; Mysliwiec M
    Transplant Proc; 2000 Sep; 32(6):1347-9. PubMed ID: 10995975
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhancement of human platelet aggregation and secretion induced by rapamycin.
    Babinska A; Markell MS; Salifu MO; Akoad M; Ehrlich YH; Kornecki E
    Nephrol Dial Transplant; 1998 Dec; 13(12):3153-9. PubMed ID: 9870481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of immunosuppressive drugs on platelet aggregation in vitro.
    Małyszko J; Małyszko JS; Takada A; Myśliwiec M
    Ann Transplant; 2002; 7(1):55-68. PubMed ID: 12221905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative investigation of the effects of the immunosuppressants cyclosporine A, cyclosporine G, and FK-506 on platelet activation.
    Fernandes JB; Naik UP; Markell MS; Kornecki E
    Cell Mol Biol Res; 1993; 39(3):265-74. PubMed ID: 7507391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of mycophenolate mofetil on platelet function.
    Knudsen GH; Nielsen C; Nielsen CB; Frederiksen H; Vinholt PJ
    Blood Coagul Fibrinolysis; 2020 Mar; 31(2):132-139. PubMed ID: 31913146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Original Article: Cyclosporine a and FK 506 Affect Platelet Functions in Vitro.
    Malyszko J; Malyszko JS; Takada A; Takada Y; Mysliwiec M
    Platelets; 1995; 6(6):366-70. PubMed ID: 21043766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of acute, moderate ethanol consumption on human platelet aggregation in platelet-rich plasma and whole blood.
    Zhang QH; Das K; Siddiqui S; Myers AK
    Alcohol Clin Exp Res; 2000 Apr; 24(4):528-34. PubMed ID: 10798590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human granulocyte colony-stimulating factor (rhG-CSF) promotes in vitro platelet aggregation.
    Kaptan K; Ifran A; Beyan C; Sertkaya D
    Hematology; 2007 Oct; 12(5):441-4. PubMed ID: 17852446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of mycophenolic acid and tacrolimus on homocysteine metabolism.
    Ignatescu MC; Kletzmayr J; Födinger M; Bieglmayer C; Hörl WH; Sunder-Plassmann G
    Kidney Int; 2002 May; 61(5):1894-8. PubMed ID: 11967042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of immunosuppressive drugs on platelet aggregation and soluble P-selectin levels in renal transplant patients.
    Sahin G; Akay OM; Kus E; Bal C; Yalcin AU; Gulbas Z
    Ren Fail; 2009; 31(2):111-7. PubMed ID: 19212907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive therapy regimen and platelet activation in renal transplant patients.
    Graff J; Klinkhardt U; Harder S; Wegert W; Lenz T; Scheuermann EH; Gossmann J
    Clin Pharmacol Ther; 2002 Oct; 72(4):411-8. PubMed ID: 12386643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF.
    Porta C; Maiolo A; Tua A; Grignani G
    Haematologica; 2000 Aug; 85(8):820-5. PubMed ID: 10942928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of mycophenolic acid and tacrolimus on Th17-related immune response.
    Abadja F; Atemkeng S; Alamartine E; Berthoux F; Mariat C
    Transplantation; 2011 Aug; 92(4):396-403. PubMed ID: 21818055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The first- and second-generation antipsychotic drugs affect ADP-induced platelet aggregation.
    Dietrich-Muszalska A; Rabe-Jablonska J; Nowak P; Kontek B
    World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):268-75. PubMed ID: 20218792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the aggregation responses of camel platelets.
    Al Ghumlas AK; Gader AG
    Vet Clin Pathol; 2013 Sep; 42(3):307-13. PubMed ID: 23919654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of combined administration of FK 506 and the purine biosynthesis inhibitors mizoribine or mycophenolic acid on lymphocyte DNA synthesis and T cell activation molecule expression in human mixed lymphocyte cultures.
    Thomson AW; Woo J; Yao GZ; Todo S; Starzl TE; Zeevi A
    Transpl Immunol; 1993; 1(2):146-50. PubMed ID: 7521738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement by cyclosporine A and tacrolimus of serotonin-induced formation of small platelet aggregation.
    Suehiro A; Sawada A; Hasegawa Y; Takatsuka H; Higasa S; Kakishita E
    Bone Marrow Transplant; 2002 Jan; 29(2):107-11. PubMed ID: 11850703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dextran 40 reduces in vitro platelet aggregation in peripheral arterial disease.
    Robless P; Okonko D; Mikhailidis DP; Stansby G
    Platelets; 2004 Jun; 15(4):215-22. PubMed ID: 15203712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.